These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 8411803)

  • 1. [Study on the cellular proliferation and endocrine activity of the parathyroid gland in hyperparathyroidism].
    Hosokawa S
    Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1424-31. PubMed ID: 8411803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: the question of adenoma and primary hyperplasia.
    van Vonderen IK; Kooistra HS; Peeters ME; Rijnberk A; van den Ingh TS
    J Comp Pathol; 2003 Jul; 129(1):61-9. PubMed ID: 12859909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
    Yamaguchi S; Yachiku S; Morikawa M
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.
    Schmid KW; Hittmair A; Ladurner D; Sandbichler P; Gasser R; Tötsch M
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):295-9. PubMed ID: 2024450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of calcium and magnesium on parathyroid hormone release from human parathyroid tissue in vitro].
    Wagner PK; Krause U; Rothmund M
    Res Exp Med (Berl); 1982; 181(3):205-10. PubMed ID: 7163647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric DNA analysis of benign hyperfunctioning parathyroid glands: significant difference in the S phase fraction and proliferative index between adenomas and hyperplasias.
    Berczi C; Bocsi J; Balázs G; Lukács G
    Pathology; 2002 Oct; 34(5):442-5. PubMed ID: 12408343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
    Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of proliferative activity of glandular cells in hyperfunctioning parathyroid gland using flow cytometric and immunohistochemical methods.
    Xiao-Lin P; Koide N; Kobayashi S; Kobayashi M; Sugenoya A; Iida F; Katsuyama T; Usuda N; Nagata T
    World J Surg; 1996; 20(3):361-6; discussion 367. PubMed ID: 8661846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
    Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
    World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
    Tanaka R; Umemura S; Kakuta T; Fujisaki T; Sakai H; Saitoh A; Osamura RY
    Pathol Res Pract; 2003; 199(2):93-9. PubMed ID: 12747471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions.
    Tseleni-Balafouta S; Thomopoulou G; Lazaris ACh; Koutselini H; Davaris PS
    Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].
    Mangili F; Sassi I; Schiaffino E; Zogno C; Cantaboni A; Schmid C
    Pathologica; 1992; 84(1092):459-65. PubMed ID: 1491887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we predict expected adenoma weight preoperatively with reference to the correlation of preoperative biochemical tests with parathyroid adenoma weight?
    Leong DCW; Lo J; Nguyen H; Ryan S
    Asian J Surg; 2020 Jul; 43(7):759-764. PubMed ID: 31699571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone release in vitro in hyperparathyroidism associated with multiple endocrine neoplasia type 1.
    Benson L; Rastad J; Ljunghall S; Rudberg C; Akerström G
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):12-7. PubMed ID: 2880443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intrathyroidal hyperfunctioning parathyroid gland.
    Sawady J; Mendelsohn G; Sirota RL; Taxy JB
    Mod Pathol; 1989 Nov; 2(6):652-7. PubMed ID: 2587570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
    Lee HJ; Seo UH; Kim WY; Woo SU; Lee JB
    J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of intact PTH by dispersed human hyperparathyroid cells.
    Aston JP; Brown RC; Curley I; Wheeler MH; Woodhead JS
    Clin Endocrinol (Oxf); 1988 Dec; 29(6):643-8. PubMed ID: 3256447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures.
    Weber CJ; Russell J; Costanzo MK; Karp F; Benjamin M; Hardy MA; Feind CR
    Surgery; 1992 Dec; 112(6):1089-94; discussion 1094-5. PubMed ID: 1455310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.
    Szende B; Farid P; Végso G; Perner F; Kopper L
    Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.
    Buchwald PC; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):389-93. PubMed ID: 15009006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.